National Academies Press: OpenBook
« Previous: Appendix C: Workshop Agenda
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine and National Research Council. 2014. Technologies to Enable Autonomous Detection for BioWatch: Ensuring Timely and Accurate Information for Public Health Officials: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18495.
×
Page 135
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine and National Research Council. 2014. Technologies to Enable Autonomous Detection for BioWatch: Ensuring Timely and Accurate Information for Public Health Officials: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18495.
×
Page 136
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine and National Research Council. 2014. Technologies to Enable Autonomous Detection for BioWatch: Ensuring Timely and Accurate Information for Public Health Officials: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18495.
×
Page 137
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine and National Research Council. 2014. Technologies to Enable Autonomous Detection for BioWatch: Ensuring Timely and Accurate Information for Public Health Officials: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18495.
×
Page 138
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine and National Research Council. 2014. Technologies to Enable Autonomous Detection for BioWatch: Ensuring Timely and Accurate Information for Public Health Officials: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18495.
×
Page 139
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine and National Research Council. 2014. Technologies to Enable Autonomous Detection for BioWatch: Ensuring Timely and Accurate Information for Public Health Officials: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18495.
×
Page 140

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

D Registered Attendees Amy Altman Jeffrey Bigongiari Luminex Corporation CBRNe World Jessica Appler Ava-Gay Blagrove Department of Homeland New York City Health Security Cynthia Boston Hazel Bailey PathSensors, Inc. Government Accounting Office Debora Boyle The Tauri Group––BioWatch Andrew Bartko SETA Battelle Memorial Institute Cindy Bruckner-Lea Linda Beck Pacific Northwest National Department of Homeland Laboratory Security Wayne Bryden Steven Bennett WA Bryden Consulting Department of Homeland Security Charles Burrus Metropolitan Transit Laura Biesiadecki Authority/New York National Association of CityTransit County and City Health Officials 135

136 TECHNOLOGIES TO ENABLE AUTONOMOUS DETECTION FOR BIOWATCH Patrick Byrne Donald Eby Department of Health and Booz Allen Hamilton Human Services Eric Eisenstadt Kathryn Callahan Private Citizen Department of Homeland Security Gerald Epstein Department of Homeland Thomas Cebula Security Johns Hopkins University Seth Faith Carol Chapman Battelle Memorial Institute Department of Homeland Security Michael Farrell Centers for Disease Control Ari Cohen and Prevention Department of Defense Jeffrey Faszcza Rita R. Colwell Catalyst Partners University of Maryland, College Park Erik Fiske Johns Hopkins University Department of Homeland Security Tod Companion Department of Homeland Eric Gard Security Lawrence Livermore National Laboratory Bernard Courtney The Tauri Group Alexander Garza FirstWatch, Inc. David Cullin FLIR Systems Jane Getchell Association of Public Health Ken Damer Laboratories Northrop Grumman Alison Graziano Chris Detter The Tauri Group Los Alamos National Laboratory David Hanlon Quanterix

APPENDIX D 137 Manzour Hazbon Stevan Jovanovich Private Citizen IntegenX Yair Hazi Robert Kadlec HWC BioWatch SPO RPK Consulting J. Jerome Holton Jordan Kanter The Tauri Group Executive Office of the President Karen House Aberdeen Proving Ground Ivor Knight Canon U.S. Life Sciences Scott Hughes New York City Public Health Charles Kolb Laboratory Aerodyne Research, Inc. Anne Hultgren Kristin Korte Department of Homeland FLIR Security David LaVan Rabih Jabbour National Institute of Standards Private Citizen and Technology Diane Jamrog Matthew Lesho Lincoln Laboratory Luminex Corporation Massachusetts Institute of Technology Beth Maldin Morgenthau New York City Department of Malcolm Johns Health and Mental Department of Homeland Hygiene Security Irene March Rudolph Johnson The Tauri Group Centers for Disease Control and Prevention Raymond Mariella, Jr. Lawrence Livermore National Franca Jones Laboratory Executive Office of the President Mickey McCarter Homeland Security Today

138 TECHNOLOGIES TO ENABLE AUTONOMOUS DETECTION FOR BIOWATCH Atelia McClelland Erica Pan Hassett Willis and Company Alameda County Public Health Department Suzet McKinney Chicago Department of Public Andreea Paulopol Health U.S. Department of State Toby Merlin David Persse Centers for Disease Control City of Houston and Prevention Sally Phillips Stephen Morse Department of Homeland Columbia University Security William Niu John Plante UTC Aerospace System Chicago Transit Authority M. Allen Northrup Don Prosnitz Northrup Consulting Group Private Citizen Joanne Michelle Ocampo William Raub Georgetown University Department of Health and Human Services Michael O’Keefe The Tauri Group—BioWatch Gary Resnick SETA IGR Consulting Ted Olsen Alan Rudolph PathSensors Department of Homeland Security Kristin Omberg Los Alamos National Jeffrey Runge Laboratory The Chertoff Group William O’Neill Paul Schaudies U.S. Postal Sevice GenArraytion, Inc. Zheng Ouyang Mark Scheckelhoff Purdue University Department of Homeland Security

APPENDIX D 139 Amy Scheuer Courtney Tauscher Department of Homeland Department of Homeland Security Security Jeffery Schloss David Tilles National Human Genome Northrop Grumman Research Institute John Vitko Umair Shah Private Citizen Harris County Public Health and Environmental Bruce Voelker Services Aberdeen Proving Ground Sushil Sharma Michael Walter General Accounting Ofiice Department of Homeland Security Jeanette Simpson Pathsensors Claire Wells Department of Homeland Thomas Slezak Security Lawrence Livermore National Laboratory S. J. Whidden Private Citizen Sandra Smole Massachusetts Department of Wayne Willis Public Health Hassett Willis and Company A. Peter Snyder Lewis Wogan Private Citizen Lawrence Livermore National Laboratory Tim Stephens National Sheriffs Association Brian Young Battelle Memorial Institute Colin Stimmler New York City Department of Health and Mental Hygiene Appavu Sundaram Private Citizen

Next: Appendix E: Technology Readiness Levels in the Department of Defense »
Technologies to Enable Autonomous Detection for BioWatch: Ensuring Timely and Accurate Information for Public Health Officials: Workshop Summary Get This Book
×
Buy Paperback | $68.00 Buy Ebook | $54.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The BioWatch program, funded and overseen by the Department of Homeland Security (DHS), has three main elements—sampling, analysis, and response—each coordinated by different agencies. The Environmental Protection Agency maintains the sampling component, the sensors that collect airborne particles. The Centers for Disease Control and Prevention coordinates analysis and laboratory testing of the samples, though testing is actually carried out in state and local public health laboratories. Local jurisdictions are responsible for the public health response to positive findings. The Federal Bureau of Investigation is designated as the lead agency for the law enforcement response if a bioterrorism event is detected. In 2003 DHS deployed the first generation of BioWatch air samplers. The current version of this technology, referred to as Generation 2.0, requires daily manual collection and testing of air filters from each monitor. DHS has also considered newer automated technologies (Generation 2.5 and Generation 3.0) which have the potential to produce results more quickly, at a lower cost, and for a greater number of threat agents.

Technologies to Enable Autonomous Detection for BioWatch is the summary of a workshop hosted jointly by the Institute of Medicine and the National Research Council in June 2013 to explore alternative cost-effective systems that would meet the requirements for a BioWatch Generation 3.0 autonomous detection system, or autonomous detector, for aerosolized agents . The workshop discussions and presentations focused on examination of the use of four classes of technologies—nucleic acid signatures, protein signatures, genomic sequencing, and mass spectrometry—that could reach Technology Readiness Level (TRL) 6-plus in which the technology has been validated and is ready to be tested in a relevant environment over three different tiers of temporal timeframes: those technologies that could be TRL 6-plus ready as part of an integrated system by 2016, those that are likely to be ready in the period 2016 to 2020, and those are not likely to be ready until after 2020. Technologies to Enable Autonomous Detection for BioWatch discusses the history of the BioWatch program, the role of public health officials and laboratorians in the interpretation of BioWatch data and the information that is needed from a system for effective decision making, and the current state of the art of four families of technology for the BioWatch program. This report explores how the technologies discussed might be strategically combined or deployed to optimize their contributions to an effective environmental detection capability.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!